arikayce liposomal
insmed netherlands b.v. - amikacin sulfate - infektionen der atemwege - antibiotika für den systemischen einsatz, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.
exparel liposomal
pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.
posaconazol viatris 40 mg/ml suspension zum einnehmen
viatris pharma gmbh - posaconazolum - suspension zum einnehmen - posaconazolum 200 mg, acidum citricum monohydricum, natrii dihydrogenocitras anhydricus, natrii benzoas 10 mg, natrii laurilsulfas, simeticonum, methylcellulosum, acidum sorbicum, xanthani gummi, glycerolum, glucosum liquidum 2108.5 mg, e 171, aromatica (kirschen), aqua purificata ad suspensionem pro 5 ml corresp. natrium 5.91 mg. - pilzinfektionen - synthetika
posaconazol viatris 100 mg magensaftresistente tablette
viatris pharma gmbh - posaconazolum - magensaftresistente tablette - posaconazolum 100 mg, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, xylitolum, hydroxypropylcellulosum, e 310, cellulosum microcristallinum, silica colloidalis anhydrica, carmellosum natricum conexum, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (flavum), pro compresso obducto corresp. natrium 2.4 mg. - pilzinfektionen - synthetika
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doxorubicinhydrochlorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastische mittel - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
liposic fluid ud augengel
bausch & lomb swiss ag - carbomerum 980 - augengel - carbomerum 980 2 mg, excipiens ad gelatum 1 g. - tränenflüssigkeitsersatz - synthetika
liposic 2 mg/g augengel
bausch & lomb pharma - carbomere - augengel - 2 mg/g - carbomere 2 mg/g - artificial tears and other indifferent preparations
lipostabil 300 mg
cassella - med gmbh & co. kg (3165486) - entölte phospholipide aus sojabohnen - hartkapsel - teil 1 - hartkapsel; entölte phospholipide aus sojabohnen (01414) 300 milligramm
lipostabil n i.v. 5ml
artegodan gmbh (8023319) - essentielle phospholipide - injektionslösung - teil 1 - injektionslösung; essentielle phospholipide (02199) 250 milligramm
grippostad guaifenesin 100 mg/ml hustentropfen zum einnehmen
stada arzneimittel gmbh - guaifenesin - guaifenesin